DAFNA Capital Management LLC
Position in RVMD — Revolution Medicines, Inc.
CIK 1389933
LOS ANGELES, CA
Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,369,346
+$48,898,411 QoQ
Shares Held
562,630
-3.1% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
21.36%
of 13F equity value
Holder Rank
#59
of 685 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. RVMD ranks #1 (30.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
This page
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in RVMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,369,346 | 562,630 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,470,935 | 580,678 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48,149,540 | 604,514 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,690,119 | 657,176 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,913,305 | 677,176 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,202,383 | 656,176 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,607,638 | 631,176 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,491,027 | 517,994 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,866,606 | 511,894 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,498,343 | 511,894 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,681,119 | 511,894 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,103,545 | 473,394 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,703,623 | 512,285 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,471,503 | 575,785 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,380,838 | 477,785 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,461,360 | 479,785 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,842,809 | 299,785 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,920,896 | 232,101 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,341,854 | 212,231 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,769,699 | 209,731 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,656,861 | 209,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,938,478 | 151,231 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $890,775 | 22,500 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||